Ocular Therapeutix Files 8-K on Financials
Ticker: OCUL · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1393434
| Field | Detail |
|---|---|
| Company | Ocular Therapeutix, Inc (OCUL) |
| Form Type | 8-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: OCUL
TL;DR
OCUL filed an 8-K on March 3rd detailing financial results and condition.
AI Summary
Ocular Therapeutix, Inc. filed an 8-K on March 3, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 15 Crosby Drive, Bedford, MA.
Why It Matters
This filing provides investors with crucial updates on Ocular Therapeutix's financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- OCULAR THERAPEUTIX, INC. (company) — Filer
- March 3, 2025 (date) — Date of earliest event reported
- 15 Crosby Drive Bedford, MA 01730 (location) — Address of Principal Executive Offices
- 001-36554 (identifier) — Commission File Number
FAQ
What specific financial information is being reported in this 8-K?
The 8-K indicates it reports on 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filing made?
The filing was made on March 3, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at 15 Crosby Drive, Bedford, MA 01730.
What is Ocular Therapeutix, Inc.'s Commission File Number?
The Commission File Number for Ocular Therapeutix, Inc. is 001-36554.
What is the SIC code for Ocular Therapeutix, Inc.?
The Standard Industrial Classification (SIC) code for Ocular Therapeutix, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding OCULAR THERAPEUTIX, INC (OCUL).